Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Getting paid online quickly is achievable with various strategies. Learn effective methods to receive your earnings faster.
18,564 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
As Commvault shares dive, a fresh $19.8 million stake signals confidence from a hedge fund with a plan. Here's how to...
Bitcoin hovers near a critical zone as traders weigh whether a floor is forming or a deeper pullback lies ahead. ETF ...
Microsoft has faced a sharp pullback as AI spending and cloud dynamics shift. This article weighs the risks and oppor...
Oil markets remain volatile amid geopolitical risk, but three U.S. majors are drawing attention for potential 50%+ re...
BNB rose on March 24, 2026, as volume surged and traders weigh whether it can reach the monthly target, boosted by st...
NVIDIA’s GTC 2026 unveiled a broader AI-infrastructure push, signaling that nvidia’s developments were bigger than in...
The bond market nearing threshold as long-term yields climb in a period of geopolitical tension and data surprises. T...
Can Trump Media outpace the broader market? This in-depth analysis breaks down the business model, risks, and the sig...
The AI stock story is shifting from last year’s heroes to new winners in 2026. This guide explains why the leadership...
Hybrids now make up about 20% of U.S. vehicle sales in Q4 2025, signaling a major shift in consumer buying and the tr...
Iran publicly spurns ceasefire talks amid renewed attacks, while the White House insists talks continue. The flare-up...